Published in Gene Therapy Weekly, April 19th, 2001
Data from this study demonstrated that RB94 caused growth arrest and induced apoptotic death in human tumor cells.
Additionally, the mechanisms of anti-tumor activity demonstrated by RB94 in these studies suggest potential for synergy with chemotherapy and radiation therapy in the treatment of cancer. These results were presented March 28, 2001, at the American Association of Cancer Research conference in New Orleans,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.